CRL logo

CRL EBITDA

annual EBITDA:

$581.14M-$450.98M(-43.69%)
December 28, 2024

Summary

  • As of today (May 29, 2025), CRL annual EBITDA is $581.14 million, with the most recent change of -$450.98 million (-43.69%) on December 28, 2024.
  • During the last 3 years, CRL annual EBITDA has fallen by -$239.02 million (-29.14%).
  • CRL annual EBITDA is now -43.69% below its all-time high of $1.03 billion, reached on December 30, 2023.

Performance

CRL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLincome statement metrics

quarterly EBITDA:

$184.23M+$270.68M(+313.09%)
March 29, 2025

Summary

  • As of today (May 29, 2025), CRL quarterly EBITDA is $184.23 million, with the most recent change of +$270.68 million (+313.09%) on March 29, 2025.
  • Over the past year, CRL quarterly EBITDA has dropped by -$35.14 million (-16.02%).
  • CRL quarterly EBITDA is now -48.43% below its all-time high of $357.25 million, reached on December 31, 2022.

Performance

CRL quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLincome statement metrics

TTM EBITDA:

$546.00M-$35.14M(-6.05%)
March 29, 2025

Summary

  • As of today (May 29, 2025), CRL TTM EBITDA is $546.00 million, with the most recent change of -$35.14 million (-6.05%) on March 29, 2025.
  • Over the past year, CRL TTM EBITDA has dropped by -$463.00 million (-45.89%).
  • CRL TTM EBITDA is now -48.81% below its all-time high of $1.07 billion, reached on September 30, 2023.

Performance

CRL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRLincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CRL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-43.7%-16.0%-45.9%
3 y3 years-29.1%-5.8%-36.4%
5 y5 years+3.2%+44.2%-4.1%

CRL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-43.7%at low-48.4%+313.1%-48.8%at low
5 y5-year-43.7%+3.2%-48.4%+313.1%-48.8%at low
alltimeall time-43.7%+263.3%-48.4%+129.3%-48.8%+229.6%

CRL EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$184.23M(-313.1%)
$546.00M(-6.0%)
Dec 2024
$581.14M(-43.7%)
-$86.45M(-141.2%)
$581.14M(-41.3%)
Sep 2024
-
$209.72M(-12.1%)
$990.36M(-1.6%)
Jun 2024
-
$238.50M(+8.7%)
$1.01B(-0.3%)
Mar 2024
-
$219.37M(-32.0%)
$1.01B(-2.2%)
Dec 2023
$1.03B(+4.7%)
$322.76M(+43.1%)
$1.03B(-3.2%)
Sep 2023
-
$225.49M(-6.6%)
$1.07B(+1.6%)
Jun 2023
-
$241.38M(-0.5%)
$1.05B(+1.7%)
Mar 2023
-
$242.49M(-32.1%)
$1.03B(+4.8%)
Dec 2022
$986.15M(+20.2%)
$357.25M(+70.9%)
$986.15M(+13.2%)
Sep 2022
-
$209.09M(-6.8%)
$871.33M(+0.1%)
Jun 2022
-
$224.24M(+14.7%)
$870.66M(+1.5%)
Mar 2022
-
$195.58M(-19.3%)
$858.21M(+4.6%)
Dec 2021
$820.16M(+6.7%)
$242.43M(+16.3%)
$820.16M(-2.8%)
Sep 2021
-
$208.41M(-1.6%)
$844.18M(-0.6%)
Jun 2021
-
$211.79M(+34.4%)
$849.49M(+6.4%)
Mar 2021
-
$157.53M(-40.9%)
$798.21M(+3.9%)
Dec 2020
$768.47M(+36.5%)
$266.45M(+24.7%)
$768.47M(+12.4%)
Sep 2020
-
$213.72M(+33.2%)
$683.78M(+13.8%)
Jun 2020
-
$160.51M(+25.6%)
$600.75M(+5.5%)
Mar 2020
-
$127.79M(-29.7%)
$569.21M(+1.1%)
Dec 2019
$563.06M(+11.0%)
$181.76M(+39.1%)
$563.06M(+9.4%)
Sep 2019
-
$130.69M(+1.3%)
$514.67M(-0.7%)
Jun 2019
-
$128.97M(+6.0%)
$518.07M(-0.6%)
Mar 2019
-
$121.64M(-8.8%)
$521.43M(+2.8%)
Dec 2018
$507.23M(+10.8%)
$133.37M(-0.5%)
$507.23M(+4.8%)
Sep 2018
-
$134.09M(+1.3%)
$484.12M(+4.3%)
Jun 2018
-
$132.33M(+23.2%)
$464.10M(+3.6%)
Mar 2018
-
$107.44M(-2.6%)
$447.89M(-2.2%)
Dec 2017
$457.89M(+21.4%)
$110.26M(-3.3%)
$457.89M(+0.8%)
Sep 2017
-
$114.07M(-1.8%)
$454.41M(+4.5%)
Jun 2017
-
$116.12M(-1.1%)
$434.78M(+4.9%)
Mar 2017
-
$117.44M(+10.0%)
$414.31M(+9.8%)
Dec 2016
$377.29M(+23.5%)
$106.78M(+13.1%)
$377.29M(+7.8%)
Sep 2016
-
$94.44M(-1.3%)
$349.88M(+4.1%)
Jun 2016
-
$95.65M(+18.9%)
$336.25M(+2.4%)
Mar 2016
-
$80.42M(+1.3%)
$328.45M(+7.6%)
Dec 2015
$305.38M(+6.8%)
$79.36M(-1.8%)
$305.38M(+3.5%)
Sep 2015
-
$80.82M(-8.0%)
$294.99M(+2.7%)
Jun 2015
-
$87.85M(+53.2%)
$287.13M(+3.5%)
Mar 2015
-
$57.34M(-16.9%)
$277.50M(-3.0%)
Dec 2014
$285.99M(+11.7%)
$68.97M(-5.5%)
$285.99M(+5.0%)
Sep 2014
-
$72.96M(-6.7%)
$272.25M(+0.4%)
Jun 2014
-
$78.22M(+18.8%)
$271.25M(+5.2%)
Mar 2014
-
$65.84M(+19.2%)
$257.83M(+0.7%)
Dec 2013
$255.93M(+4.7%)
$55.23M(-23.2%)
$255.93M(+0.0%)
Sep 2013
-
$71.96M(+11.0%)
$255.87M(+6.0%)
Jun 2013
-
$64.80M(+1.3%)
$241.38M(-1.4%)
Mar 2013
-
$63.94M(+15.9%)
$244.72M(+0.1%)
Dec 2012
$244.36M
$55.17M(-4.0%)
$244.36M(-3.3%)
Sep 2012
-
$57.46M(-15.7%)
$252.79M(-0.1%)
DateAnnualQuarterlyTTM
Jun 2012
-
$68.14M(+7.2%)
$252.98M(-2.7%)
Mar 2012
-
$63.58M(-0.0%)
$260.12M(-0.1%)
Dec 2011
$260.48M(-227.0%)
$63.60M(+10.3%)
$260.48M(-282.3%)
Sep 2011
-
$57.65M(-23.4%)
-$142.92M(-16.9%)
Jun 2011
-
$75.28M(+17.7%)
-$172.03M(-11.7%)
Mar 2011
-
$63.94M(-118.8%)
-$194.87M(-5.0%)
Dec 2010
-$205.15M(-177.9%)
-$339.80M(-1290.3%)
-$205.15M(-208.4%)
Sep 2010
-
$28.55M(-45.6%)
$189.23M(-18.3%)
Jun 2010
-
$52.43M(-2.3%)
$231.53M(-9.1%)
Mar 2010
-
$53.66M(-1.7%)
$254.63M(-3.3%)
Dec 2009
$263.20M(-174.0%)
$54.59M(-23.0%)
$263.20M(-162.5%)
Sep 2009
-
$70.85M(-6.2%)
-$421.17M(+5.3%)
Jun 2009
-
$75.54M(+21.4%)
-$399.97M(+4.9%)
Mar 2009
-
$62.23M(-109.9%)
-$381.37M(+7.2%)
Dec 2008
-$355.82M(-210.6%)
-$629.78M(-784.2%)
-$355.82M(-200.0%)
Sep 2008
-
$92.05M(-2.2%)
$355.65M(+1.7%)
Jun 2008
-
$94.13M(+7.2%)
$349.82M(+4.6%)
Mar 2008
-
$87.78M(+7.5%)
$334.27M(+3.9%)
Dec 2007
$321.81M(+17.7%)
$81.68M(-5.3%)
$321.81M(+4.5%)
Sep 2007
-
$86.22M(+9.7%)
$307.81M(+4.3%)
Jun 2007
-
$78.59M(+4.4%)
$295.00M(+3.4%)
Mar 2007
-
$75.31M(+11.3%)
$285.19M(+96.8%)
Dec 2006
$273.30M(-0.5%)
$67.69M(-7.8%)
$144.94M(+11.8%)
Sep 2006
-
$73.40M(+6.7%)
$129.63M(-6.3%)
Jun 2006
-
$68.79M(-205.9%)
$138.34M(+0.5%)
Mar 2006
-
-$64.93M(-224.0%)
$137.62M(-49.8%)
Dec 2005
$274.81M(+36.1%)
$52.38M(-36.2%)
$274.02M(+0.9%)
Sep 2005
-
$82.11M(+20.6%)
$271.66M(+12.5%)
Jun 2005
-
$68.06M(-4.8%)
$241.40M(+7.0%)
Mar 2005
-
$71.47M(+42.9%)
$225.69M(+11.8%)
Dec 2004
$201.92M(+19.0%)
$50.02M(-3.5%)
$201.92M(+2.9%)
Sep 2004
-
$51.86M(-0.9%)
$196.18M(+5.3%)
Jun 2004
-
$52.34M(+9.7%)
$186.23M(+5.6%)
Mar 2004
-
$47.70M(+7.7%)
$176.34M(+3.9%)
Dec 2003
$169.67M(+14.7%)
$44.28M(+5.7%)
$169.67M(+3.9%)
Sep 2003
-
$41.91M(-1.3%)
$163.25M(+1.6%)
Jun 2003
-
$42.46M(+3.5%)
$160.70M(+3.8%)
Mar 2003
-
$41.03M(+8.4%)
$154.80M(+4.6%)
Dec 2002
$147.99M(+24.5%)
$37.86M(-3.8%)
$147.99M(+5.1%)
Sep 2002
-
$39.36M(+7.7%)
$140.80M(+5.9%)
Jun 2002
-
$36.56M(+6.8%)
$132.94M(+4.0%)
Mar 2002
-
$34.22M(+11.6%)
$127.81M(+7.5%)
Dec 2001
$118.86M(+41.6%)
$30.67M(-2.6%)
$118.86M(+11.3%)
Sep 2001
-
$31.49M(+0.2%)
$106.78M(+9.2%)
Jun 2001
-
$31.44M(+24.4%)
$97.81M(+13.3%)
Mar 2001
-
$25.27M(+36.0%)
$86.36M(+2.9%)
Dec 2000
$83.93M(+43.2%)
$18.58M(-17.5%)
$83.93M(+28.4%)
Sep 2000
-
$22.53M(+12.7%)
$65.35M(+52.6%)
Jun 2000
-
$19.98M(-12.5%)
$42.82M(+87.5%)
Mar 2000
-
$22.84M
$22.84M
Dec 1999
$58.61M(+26.8%)
-
-
Dec 1998
$46.22M
-
-

FAQ

  • What is Charles River Laboratories International annual EBITDA?
  • What is the all time high annual EBITDA for Charles River Laboratories International?
  • What is Charles River Laboratories International annual EBITDA year-on-year change?
  • What is Charles River Laboratories International quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Charles River Laboratories International?
  • What is Charles River Laboratories International quarterly EBITDA year-on-year change?
  • What is Charles River Laboratories International TTM EBITDA?
  • What is the all time high TTM EBITDA for Charles River Laboratories International?
  • What is Charles River Laboratories International TTM EBITDA year-on-year change?

What is Charles River Laboratories International annual EBITDA?

The current annual EBITDA of CRL is $581.14M

What is the all time high annual EBITDA for Charles River Laboratories International?

Charles River Laboratories International all-time high annual EBITDA is $1.03B

What is Charles River Laboratories International annual EBITDA year-on-year change?

Over the past year, CRL annual EBITDA has changed by -$450.98M (-43.69%)

What is Charles River Laboratories International quarterly EBITDA?

The current quarterly EBITDA of CRL is $184.23M

What is the all time high quarterly EBITDA for Charles River Laboratories International?

Charles River Laboratories International all-time high quarterly EBITDA is $357.25M

What is Charles River Laboratories International quarterly EBITDA year-on-year change?

Over the past year, CRL quarterly EBITDA has changed by -$35.14M (-16.02%)

What is Charles River Laboratories International TTM EBITDA?

The current TTM EBITDA of CRL is $546.00M

What is the all time high TTM EBITDA for Charles River Laboratories International?

Charles River Laboratories International all-time high TTM EBITDA is $1.07B

What is Charles River Laboratories International TTM EBITDA year-on-year change?

Over the past year, CRL TTM EBITDA has changed by -$463.00M (-45.89%)
On this page